Insulinotropin
Alternative Names: GLP-1 (7-37); Glucagon-like peptide-1 (7-37)Latest Information Update: 14 Feb 2008
At a glance
- Originator Massachusetts General Hospital
- Developer Scios
- Class Glucagon-like peptides
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 13 Jul 2001 No-Development-Reported for Diabetes mellitus in Denmark (IV-injection)
- 13 Jul 2001 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
- 16 Sep 1999 Phase-II clinical trials for Diabetes mellitus in Denmark (IV-injection)